Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Express Scripts
UBS
Teva
Daiichi Sankyo

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 9,216,206

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,216,206
Title:Methods of treating symptoms associated with menopause and hormonal variations with G-CSF
Abstract: The invention provides for compositions and methods of treating or ameliorating menopausal symptoms and/or symptoms associated with hormonal variations by administering granulocyte colony-stimulating factor (G-CSF). The invention also provides for compositions and methods of treating or ameliorating arthritis using G-CSF.
Inventor(s): Duke; Debra M. (Denver, CO), Duke; Richard C. (Denver, CO)
Assignee: MenoGeniX, Inc. (Aurora, CO)
Application Number:13/055,368
Patent Claims:see list of patent claims

Details for Patent 9,216,206

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Sign Up MenoGeniX, Inc. (Aurora, CO) ➤ Sign Up RX Orphan search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up MenoGeniX, Inc. (Aurora, CO) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20 ➤ Sign Up MenoGeniX, Inc. (Aurora, CO) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20 ➤ Sign Up MenoGeniX, Inc. (Aurora, CO) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up MenoGeniX, Inc. (Aurora, CO) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Cipla
Citi
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.